Latest Breaking News On - Pluri inc - Page 1 : vimarsana.com

Pluri : Investor Presentation – Q2 2024 - MarketScreener

Nasdaq: PLUR TASE: PLUR.TA INVESTOR PRESENTATION May, 2024 FORWARD LOOKING...

Novel Medical Food Solution for the Elderly: Pluri & Wilk Collaborate to Develop Human Breast Milk-Derived Food Production on a Commercial Scale

Pluri (NASDAQ:PLUR) Stock Price Down 1.3%

Pluri Inc. (NASDAQ:PLUR – Get Free Report)’s share price traded down 1.3% during trading on Friday . The stock traded as low as $5.94 and last traded at $6.19. 12,481 shares changed hands during trading, a decline of 46% from the average session volume of 23,133 shares. The stock had previously closed at $6.27. Pluri […]

Unleashing the Power of MAIT Cells: Pluri Launches Novel Immunotherapy Platform for Solid Tumor Cancer Treatment

Pluri : NOTICE OF ANNUAL MEETING OF SHAREHOLDERS To Be Held On June 25, 2024

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A ...

Pluri : 2023 Annual Report - MarketScreener

CELL-BASED TECHNOLOGY PLATFORMS 2023 Annual Report ...

Pluri (NASDAQ:PLUR) & Tenaya Therapeutics (NASDAQ:TNYA) Financial Review

Pluri (NASDAQ:PLUR – Get Free Report) and Tenaya Therapeutics (NASDAQ:TNYA – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, dividends, earnings, profitability, valuation, institutional ownership and risk. Insider & Institutional Ownership 16.6% of Pluri shares […]

Breakthrough In Immune Cell Expansion: Pluri Granted U.S Patent For New Method

Pluri : Business Verticals Gain Traction in Global Markets; Leadership to Participate and Present in Upcoming Conferences -March 28, 2024 at 07:14 am EDT

This file has been cleaned of potential threats. If you confirm that the file is coming from a trusted source, you can send the following SHA-256 hash value to...

Pluri Inc. Announces 1-for-8 Reverse Share Split